RO102780B1 - General anaesthesia method - Google Patents

General anaesthesia method

Info

Publication number
RO102780B1
RO102780B1 RO136033A RO13603388A RO102780B1 RO 102780 B1 RO102780 B1 RO 102780B1 RO 136033 A RO136033 A RO 136033A RO 13603388 A RO13603388 A RO 13603388A RO 102780 B1 RO102780 B1 RO 102780B1
Authority
RO
Romania
Prior art keywords
general anaesthesia
dose
anaesthesia method
piafen
fentanyl
Prior art date
Application number
RO136033A
Other languages
Romanian (ro)
Other versions
RO102780A2 (en
Inventor
Artur Ion Petre Tica
Dora Mary Vania Tica
Aurel Barbulescu
Vlad Iustin Tica
Tania Ortansa Nicolau
Andrei Adrian Tica
Original Assignee
Spitalul Clinic Nr. 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spitalul Clinic Nr. 1 filed Critical Spitalul Clinic Nr. 1
Priority to RO136033A priority Critical patent/RO102780B1/en
Publication of RO102780A2 publication Critical patent/RO102780A2/en
Publication of RO102780B1 publication Critical patent/RO102780B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Metoda conform inventiei consta în aceea ca se administreaza i.v. Fentanil în doza de 0,15 mg/kg corp ca doza de început apoi în doze de 0,1 ... 0,2 mg/kg corp la intervale de 20 min, continuând analgezia realizata cu Piafen, injectat succesiv, începând cu 40 ... 50 minînainte de terminarea interventiei chirurgicale câte 5 ml, mai întâi i.m. apoi i.v. la interval de 3 ... 5 min si în continuare - potrivit desfasurarii anesteziei - în 250 ml glucoza, 5 ... 10 % perfuzata i.v., cu debit de 80 ... 160 pic/min.The method according to the invention consists in administering i.v. Fentanyl at the dose of 0.15 mg / kg body weight as the starting dose then at doses of 0.1 ... 0.2 mg / kg body at 20 min intervals, continuing analgesia with Piafen, injected sequentially, beginning with 40 ... 50 mins before the end of surgery 5 ml, first im then i.v. at 3 ... 5 min. and further - according to anesthesia - in 250 ml of glucose, 5 ... 10% perfused i.v., with a flow rate of 80 ... 160 pic / min.

RO136033A 1988-11-24 1988-11-24 General anaesthesia method RO102780B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO136033A RO102780B1 (en) 1988-11-24 1988-11-24 General anaesthesia method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO136033A RO102780B1 (en) 1988-11-24 1988-11-24 General anaesthesia method

Publications (2)

Publication Number Publication Date
RO102780A2 RO102780A2 (en) 1991-10-01
RO102780B1 true RO102780B1 (en) 1991-12-30

Family

ID=20122890

Family Applications (1)

Application Number Title Priority Date Filing Date
RO136033A RO102780B1 (en) 1988-11-24 1988-11-24 General anaesthesia method

Country Status (1)

Country Link
RO (1) RO102780B1 (en)

Also Published As

Publication number Publication date
RO102780A2 (en) 1991-10-01

Similar Documents

Publication Publication Date Title
GR3031448T3 (en) Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine.
RU94040387A (en) Nicotine-containing composition
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
GR3007251T3 (en)
PL345959A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
HK1040631A1 (en) Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues.
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
MY101207A (en) Treatment of diseases caused by retroviruses
UA26988C2 (en) Method for sedating a patient and transdermal therapeutic system
GB9724267D0 (en) Novel formulations for transdermal delivery of pergolide
HUP0001237A2 (en) Methods for treating vascular disorders
TW234691B (en)
EP0459666A3 (en) Medicaments against impotence
GR3034186T3 (en) 3,4-diarylchromans for treatment of dermatitis
NZ507203A (en) Use of dexmedetomidine for ICU sedation
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
JPS6483020A (en) Medicinal composition for preventing or treating aids
RO102780B1 (en) General anaesthesia method
EP0803256A4 (en) Drug for relieving side effects caused by immunosuppressants
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
EP0166056A3 (en) Pharmaceutical dosage unit
FR2160293A1 (en) Aqueous poly(1,1'-dimethyl-1-sila-2,6-dioxa-4-hexanol) compsn - with antiinflammatory and reticuloendothelial activity
Náfráadi et al. The effect of prostacyclin and its analogues on cysteamine-induced duodenal ulceration of rats
JPS57126422A (en) Stabilizing method of lysozyme pharmaceutical
MD197G2 (en) Preparation and method for hypogalactia treatment